Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate 
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock 
OLATHE, Kan., March 01, 2016 -- Innara Health today announced that a multi-center randomized control trial (RCT) has shown that premature infants who received treatment with the NTrainer System® demonstrated improved transition to independent oral feeding. The improvements led to reduced use of feeding tubes and a reduction in length of stay (LOS) in the neonatal intensive care unit (NICU). Dr. Dongli Song, the principal investigator of the trial at Santa Clara Valley Medical Center in San Jose, California, received notification that the Pediatric Academic Societies (PAS) group has accepted two abstracts for poster presentation at the annual meeting.
“We are excited to have the opportunity to present our study at PAS. Achieving independent oral feeding represents an essential developmental milestone for premature infants. We need innovative therapies to improve their feeding readiness,” said Dr. Song. “I hope our presentation at this international conference will bring greater attention to this important issue.”
“This is an exciting development that will help the neonatal community better understand the developmental needs and capabilities of the premature infant,” said Michael Peck, CEO of Innara Health. “The reduced requirement for tube feeding, supported by the trial, could result in improved patient safety and reduced healthcare costs, as well as help these infants get home to their families sooner.”
The poster presentation of the trial will demonstrate objective data from 189 patients in a randomized control trial conducted at Santa Clara Valley Medical Center in San Jose, California; Children's Hospital at Montefiore-Weiler Division, Albert Einstein College of Medicine in Bronx, New York; Cook Children's Medical Center in Fort Worth, Texas; Children's Hospital at Montefiore-Wakefield Division, Albert Einstein College of Medicine in Bronx, New York; and North Central Baptist Hospital in San Antonio, Texas. The two poster sessions are scheduled to be presented at PAS in late April 2016.
About Innara Health
Innara Health’s mission is to advance the global understanding and improvement of neonatal, pediatric and adult feeding. The company offers the FDA-cleared NTrainer System, the first neonatal technology that assesses and develops non-nutritive suck (NNS) for newborns and infants born prematurely. Neonatal clinicians use the NTrainer System in children’s hospitals, medical centers and rehabilitation hospitals. For more information, visit innarahealth.com.
Contact Wendy Slatery Telephone 913-742-4456 E-mail [email protected]
